Elekta AB Research and Development Expenses 2013-2025 | EKTAY
Elekta AB research and development expenses from 2013 to 2025. Research and development expenses can be defined as an expense arising from studies and product development processes.
| Elekta AB Annual Research and Development Expenses (Millions of US $) |
|
|---|---|
| 2024 | $132 |
| 2023 | $136 |
| 2022 | $154 |
| 2021 | $170 |
| 2020 | $172 |
| 2019 | $176 |
| 2018 | $132 |
| 2017 | $116 |
| 2016 | $127 |
| 2015 | $128 |
| 2014 | $133 |
| 2013 | $107 |
| 2012 | $92 |
| Elekta AB Quarterly Research and Development Expenses (Millions of US $) |
|
|---|---|
| 2025-01-31 | $40 |
| 2024-10-31 | $41 |
| 2024-07-31 | $41 |
| 2024-04-30 | $34 |
| 2024-01-31 | $33 |
| 2023-10-31 | $29 |
| 2023-07-31 | $36 |
| 2023-04-30 | $29 |
| 2023-01-31 | $35 |
| 2022-10-31 | $34 |
| 2022-07-31 | $38 |
| 2022-04-30 | $35 |
| 2022-01-31 | $38 |
| 2021-10-31 | $36 |
| 2021-07-31 | $46 |
| 2021-04-30 | $41 |
| 2021-01-31 | $45 |
| 2020-10-31 | $43 |
| 2020-07-31 | $41 |
| 2020-04-30 | $40 |
| 2020-01-31 | $44 |
| 2019-10-31 | $43 |
| 2019-07-31 | $46 |
| 2019-04-30 | $45 |
| 2019-01-31 | $44 |
| 2018-10-31 | $46 |
| 2018-07-31 | $42 |
| 2018-04-30 | $28 |
| 2018-01-31 | $32 |
| 2017-10-31 | $35 |
| 2017-07-31 | $37 |
| 2017-04-30 | $32 |
| 2017-01-31 | $29 |
| 2016-10-31 | $26 |
| 2016-07-31 | $30 |
| 2016-04-30 | $29 |
| 2016-01-31 | $32 |
| 2015-10-31 | $33 |
| 2015-07-31 | $33 |
| 2015-04-30 | $29 |
| 2015-01-31 | $29 |
| 2014-10-31 | $32 |
| 2014-07-31 | $38 |
| 2014-04-30 | $31 |
| 2014-01-31 | $34 |
| 2013-10-31 | $34 |
| 2013-07-31 | $33 |
| 2013-04-30 | $22 |
| 2013-01-31 | $30 |
| 2012-10-31 | $27 |
| 2012-07-31 | $28 |
| 2012-04-30 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MED INSTRUMENTS | $1.949B | $1.704B |
| Elekta AB is a human care company engaged in developing and selling clinical solutions for the treatment of cancer and neurological diseases. It develops tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. The Company's offering is divided into five areas: Neuroscience, Oncology, Software, Brachytherapy and Services. Elekta AB is headquartered in Stockholm, Sweden. | |||